ADUS, US0067391062

Addus HomeCare Corp stock (US0067391062): Expansion into Indiana via HomeCourt acquisition

08.05.2026 - 19:58:03 | ad-hoc-news.de

Addus HomeCare Corp is entering Indiana through the acquisition of HomeCourt Home Care, marking a new state for its home health and personal care operations.

ADUS, US0067391062
ADUS, US0067391062

Addus HomeCare Corp is expanding its footprint into Indiana with the acquisition of HomeCourt Home Care, a local provider of in?home personal care services. The deal gives Addus access to a new, “very attractive” state market and adds to its growing network of home health and personal care operations across the United States, according to a sector news report on the transaction dated May 7, 2026.

As of: 08.05.2026

By the editorial team – specialized in equity coverage.

At a glance

  • Name: Addus HomeCare Corp
  • Sector/industry: Health Services / Medical and Nursing Services
  • Headquarters/country: Frisco, Texas, United States
  • Core markets: United States
  • Key revenue drivers: Personal care, hospice, and home health services
  • Home exchange/listing venue: Nasdaq (ticker: ADUS)
  • Trading currency: USD

Addus HomeCare Corp: core business model

Addus HomeCare Corp provides in?home personal care, hospice, and home health services to older adults and individuals with chronic or disabling conditions. The company operates through three main segments: Personal Care, Hospice, and Home Health. The Personal Care segment focuses on non?medical assistance with activities of daily living for people at risk of hospitalization or institutionalization, such as the elderly or disabled. The Hospice segment delivers physical, emotional, and spiritual care for terminally ill patients and support for their families. The Home Health segment offers skilled nursing and therapy services for individuals recovering from illness or hospitalization.

By delivering care in the home, Addus aims to help patients avoid or reduce the need for more costly institutional settings such as nursing homes or hospitals. This model aligns with broader trends in U.S. healthcare toward value?based care and reduced acute?care utilization, which can be attractive to payers and government programs that reimburse home?based services.

Main revenue and product drivers for Addus HomeCare Corp

Personal care services represent a core revenue driver for Addus, supported by long?term demographic trends in the United States, including an aging population and rising demand for in?home support. The company’s hospice and home health segments add higher?acuity, medically oriented services that can command different reimbursement rates and payer mixes. Recent financial data cited by a market data provider indicate that Addus generated about $1.115 billion in revenue over the 12 months ending June 2024, with quarterly revenue in the mid?$340 million range and net income in the low?$20 million range per quarter, reflecting a modest but positive earnings profile.

Expansion into new states, such as Indiana via the HomeCourt Home Care acquisition, is intended to broaden Addus’s geographic footprint and diversify its payer and referral base. Entering additional markets can help the company scale its operating model, spread fixed costs, and capture incremental volume from both public and private payers. For U.S. investors, this growth?through?acquisition strategy adds optionality but also introduces integration and regulatory risks typical of the home health and hospice sector.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Conclusion

Addus HomeCare Corp’s move into Indiana through the HomeCourt Home Care acquisition underscores its strategy of geographic expansion in the U.S. home health and personal care market. The company’s diversified service mix—personal care, hospice, and home health—positions it to benefit from aging demographics and ongoing demand for in?home care, while its Nasdaq listing provides U.S. retail investors with direct exposure to this segment. However, investors should also weigh the risks associated with regulatory changes, reimbursement pressures, and the execution of integration plans for newly acquired operations.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

So schätzen die Börsenprofis ADUS Aktien ein!

<b>So schätzen die Börsenprofis ADUS Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
FĂĽr. Immer. Kostenlos.
en | US0067391062 | ADUS | boerse | 69294599 |